It is essential to have these data since oncogenic mutations in the RAS genes, as has been said, are very frequent in colorectal cancer, affecting approximately 40% of cases, of which 85% refer to the KRAS mutation, especially codons 12, 13, and 61. The gene discussed is KRAS; the disease is colorectal cancer.